Limited_JJ
proteolysis_NN
for_IN
assaying_VBG
ligand_NN
binding_NN
affinities_NNS
of_IN
nuclear_JJ
receptors_NNS
._.

The_DT
binding_NN
of_IN
natural_JJ
or_CC
synthetic_JJ
ligands_NNS
to_TO
nuclear_JJ
receptors_NNS
is_VBZ
the_DT
triggering_NN
event_NN
leading_VBG
to_TO
gene_NN
transcription_NN
activation_NN
or_CC
repression_NN
._.

Ligand_NN
binding_NN
to_TO
the_DT
ligand_NN
binding_NN
domain_NN
of_IN
these_DT
receptors_NNS
induces_VBZ
conformational_JJ
changes_NNS
that_WDT
are_VBP
evidenced_VBN
by_IN
an_DT
increased_VBN
resistance_NN
of_IN
this_DT
domain_NN
to_TO
proteases_NNS
._.

In_FW
vitro_FW
labeled_VBN
receptors_NNS
were_VBD
incubated_VBN
with_IN
various_JJ
synthetic_JJ
or_CC
natural_JJ
agonists_NNS
or_CC
antagonists_NNS
and_CC
submitted_VBN
to_TO
trypsin_NN
digestion_NN
._.

Proteolysis_NN
products_NNS
were_VBD
separated_VBN
by_IN
SDS-PAGE_NN
and_CC
quantified_VBN
._.

The_DT
amount_NN
of_IN
trypsin-resistant_JJ
fragments_NNS
was_VBD
proportional_JJ
to_TO
receptor_NN
occupancy_NN
by_IN
the_DT
ligand_NN
,_,
and_CC
allowed_VBD
the_DT
determination_NN
of_IN
dissociation_NN
constants_NNS
-LRB-_-LRB-
kDa_NN
-RRB-_-RRB-
._.

Using_VBG
the_DT
wild-type_JJ
or_CC
mutated_VBN
human_JJ
retinoic_JJ
acid_NN
receptor_NN
alpha_NN
as_IN
a_DT
model_NN
,_,
kDa_NN
values_NNS
determined_VBN
by_IN
classical_JJ
competition_NN
binding_NN
assays_NNS
using_VBG
tritiated_JJ
ligands_NNS
are_VBP
in_IN
agreement_NN
with_IN
those_DT
measured_VBN
by_IN
the_DT
proteolytic_JJ
assay_NN
._.

This_DT
method_NN
was_VBD
successfully_RB
extended_VBN
to_TO
human_JJ
retinoic_JJ
X_NN
receptor_NN
alpha_NN
,_,
glucocorticoid_NN
receptor_NN
,_,
and_CC
progesterone_NN
receptor_NN
,_,
thus_RB
providing_VBG
a_DT
basis_NN
for_IN
a_DT
new_JJ
,_,
faster_JJR
assay_NN
to_TO
determine_VB
simultaneously_RB
the_DT
affinity_NN
and_CC
conformation_NN
of_IN
receptors_NNS
when_WRB
bound_VBN
to_TO
a_DT
given_JJ
ligand_NN
._.

